Company attributes
Industry
B2X
0
Founder
Number of Employees (Ranges)
11 – 500
Founded Date
2009
Key People
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Sangel Capital is a venture capital that is primarily interested in biomedical companies. The firm was founded in Shenzhen, Guangdong, China. The firm is interested in investing in seed-stage and early-stage venture opportunities. Sangel Capital has invested a total of in eight companies which include Denovo Biopharma, BrainNow, Magpi Pharmaceuticals, Refuge Biotechnologies, Predicine, Ultivue, and several more. The firm is know for their operations in the Asia-Pacific region of the world, and is currently active.
Timeline
No Timeline data yet.
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
